Cyclerion Therapeutics (CYCN) Receivables - Other (2019 - 2020)
Cyclerion Therapeutics (CYCN) recorded quarterly Receivables - Other of $127000.0 in Q4 2020, down 68.25% quarter-over-quarter from $400000.0 in Q3 2020, and down 91.53% on a YoY basis from $1.5 million in Q1 2020.
Cyclerion Therapeutics (CYCN) Receivables - Other (2019 - 2020) Analysis & Trends
Cyclerion Therapeutics' Receivables - Other history runs 2 years deep, the most recent figure standing at $127000.0 for Q4 2020.
- In Q4 2020, Receivables - Other fell 91.53% year-over-year to $127000.0; the TTM figure through Dec 2020 stood at $127000.0 (down 91.53% YoY), while the FY2020 annual figure was $100000.0, down 93.33% from the prior year.
- Receivables - Other was $127000.0 for Q4 2020 at Cyclerion Therapeutics, down from $400000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $1.6 million in Q2 2019 to a low of $127000.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 127,000.00 |
| Dec 31, 2020 | 127,000.00 |
| Sep 30, 2020 | 400,000.00 |
| Sep 30, 2020 | 400,000.00 |
| Jun 30, 2020 | 751,000.00 |
| Jun 30, 2020 | 751,000.00 |
| Mar 31, 2020 | 1.00 Mn |
| Mar 31, 2020 | 1.00 Mn |
| Dec 31, 2019 | 1.50 Mn |
| Dec 31, 2019 | 1.50 Mn |
| Sep 30, 2019 | 1.40 Mn |
| Sep 30, 2019 | 1.40 Mn |
| Jun 30, 2019 | 1.60 Mn |
| Jun 30, 2019 | 1.60 Mn |